Evidence map›Paper›PMID 24388650›Full record

ArticleTuberculosis (Edinburgh, Scotland)2013

Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection.

Magdalena Cepeda, Mary Salas, Jessica Folwarczny, Ana C Leandro, Vida L Hodara, Melissa A de la Garza, Edward J Dick, Michael Owston, Lisa Y Armitige, Marie-Claire Gauduin

Open access · greenAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. One Size Fits All? Not inFrontiers in cellular and infection microbiology · 2021
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Magdalena CepedaTexas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, Texas 78227, USA.
Mary SalasTexas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, Texas 78227, USA.
Jessica FolwarcznyTexas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, Texas 78227, USA.
Ana C LeandroTexas Biomedical Research Institute, Department of Genetic, San Antonio, Texas 78227, USA.
Vida L HodaraTexas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, Texas 78227, USA; Southwest National Primate Research Center, San Antonio, Texas 78227, USA.
Melissa A de la GarzaSouthwest National Primate Research Center, San Antonio, Texas 78227, USA.
Edward J DickSouthwest National Primate Research Center, San Antonio, Texas 78227, USA.
Michael OwstonSouthwest National Primate Research Center, San Antonio, Texas 78227, USA.
Lisa Y ArmitigeHeartland National TB Center, San Antonio, Texas 78223, USA; University of Texas Health Science Center, Division of Adult Infectious Diseases, Tyler, Texas 75708, USA.
Marie-Claire GauduinTexas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, Texas 78227, USA; Southwest National Primate Research Center, San Antonio, Texas 78227, USA. Electronic address: mcgauduin@txbiomed.org.
Texas Biomedical Research Institute · USThe University of Texas Health Science Center at Tyler · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
NCRR NIH HHS P51 RR013986NCRR NIH HHS P51 RR013986-11S2NIH HHS P51 OD011133
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) is the causative agent of human tuberculosis (TB) with an estimated 8.8 million new TB cases and 1.4 million deaths annually. Tuberculosis is the leading cause of death in AIDS patients worldwide but very little is known about early TB infection or TB/HIV co-infection in infants. A clinically relevant newborn animal model to study TB infection is urgently needed. We have successfully established an aerosol newborn/infant model in neonatal nonhuman primates (NHPs) that mimics clinical and bacteriological characteristics of Mtb infection as seen in human newborns/infants. Further, this model will allow the establishment of a TB coinfection model of pediatric AIDS. Aerosol versus intra broncho-alveolar Mtb infection was studied. Interestingly, 42 days post infection specific lesions were detected suggestive of the classic Ghon focus in human children. Concurrently, specific cellular immune responses developed 4-6 weeks after Mtb infection. Using the enzyme-linked immunospot (ELISPOT) assays, we found that IL-12 production correlated with early Mtb infection lesions seen by routine thoracic radiographs. Overall, this work represents the first example of early Mtb infection of newborn macaques. This study gives us a unique opportunity to further characterize immunopathogenesis and establish a TB/SIV co-infection model for pediatric AIDS.

Indexed as

Mycobacterium tuberculosisAdaptive ImmunityAdministration, InhalationAnimalsAnimals, NewbornAntigens, BacterialBody TemperatureBody WeightCoinfectionDisease Models, AnimalEnzyme-Linked Immunospot AssayFlow CytometryImmunity, CellularInterleukin-12Macaca mulattaSimian Acquired Immunodeficiency SyndromeAntigens, BacterialInterleukin-12ELISPOT IL-12Ghon focusnewbornrhesus macaqueTB

Identifiers

PMID24388650
PMCPMC4051704
OpenAlexW2066058887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.